XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Oct. 03, 2025
Sep. 27, 2024
Sep. 29, 2023
Cash flows from operating activities of Continuing Operations:      
Net income from Continuing Operations $ 326,870 $ 261,893 $ 447,098
Adjustments to reconcile Net income from Continuing Operations to Net cash provided by operating activities of Continuing Operations:      
Depreciation and amortization 476,345 435,547 409,857
Asset write-downs 8,946 18,186 29,865
Reduction of contingent consideration liability 11,127 (8,710) (97,336)
Loss (Gain) on equity investments, net (see Note 1) 19,465 (25,071) (375,972)
Deferred income taxes 14,219 (7,323) 100,158
Share-based compensation expense 58,643 62,552 76,337
Changes in operating assets and liabilities:      
Receivables, net (74,477) (99,788) (177,873)
Inventories (24,088) (3,826) (35,333)
Prepayments and other current assets (46,100) (2,660) (9,352)
Accounts payable 115,595 105,868 115,437
Accrued expenses 80,466 14,420 87,206
Payments made to clients on contracts (123,113) (139,003) (119,217)
Changes in other noncurrent liabilities (15,577) (1,222) 16,313
Changes in other assets 63,807 58,929 43,187
Other operating activities 28,907 56,722 1,272
Net cash provided by operating activities of Continuing Operations 921,035 726,514 511,647
Cash flows from investing activities of Continuing Operations:      
Purchases of property and equipment and other (489,240) (427,425) (383,536)
Disposals of property and equipment 22,667 23,945 18,060
Purchases of marketable securities 0 (113,303) (109,998)
Proceeds from marketable securities 43,936 186,371 80,000
Acquisition of certain businesses, net of cash acquired (263,567) (148,706) (50,194)
Acquisition of certain equity investments (25,877) (34,185) (4,000)
Proceeds from sale of equity investments 0 101,198 633,179
Other investing activities (10,343) (3,757) 40,147
Net cash (used in) provided by investing activities of Continuing Operations (722,424) (415,862) 223,658
Cash flows from financing activities of Continuing Operations:      
Proceeds from long-term borrowings 1,968,269 571,288 1,286,526
Payments of long-term borrowings (1,922,490) (2,003,566) (1,902,245)
Net change in funding under the Receivables Facility 0 0 (104,935)
Payments of dividends (110,821) (99,901) (114,614)
Distribution from Vestis 0 0 1,456,701
Proceeds from issuance of common stock 42,973 36,573 45,602
Repurchase of common stock (169,827) (14,395) (23,662)
Payments for contingent considerations (33,604) (12,807) (1,534)
Other financing activities (9,128) (38,388) 17,788
Net cash (used in) provided by financing activities of Continuing Operations (234,628) (1,561,196) 659,627
Discontinued Operations:      
Net cash provided by operating activities 0 0 254,782
Net cash used in investing activities 0 0 (14,746)
Net cash provided by financing activities 0 0 3,322
Net cash provided by Discontinued Operations 0 0 243,358
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 10,548 10,790 4,697
(Decrease) increase in cash and cash equivalents and restricted cash (25,469) (1,239,754) 1,642,987
Cash and cash equivalents and restricted cash, beginning of period 732,613 [1] 2,008,418 365,431 [1]
Cash and cash equivalents and restricted cash, end of period 707,144 732,613 [1] 2,008,418
Cash and cash equivalents and restricted cash, beginning of period 732,613 1,972,367 [1]  
Cash and cash equivalents and restricted cash, end of period   $ 732,613 $ 1,972,367 [1]
Cash and cash equivalents in current assets of discontinued operations $ 36,100    
[1]
(1) As a result of the separation and distribution of the Uniform segment, "Cash and cash equivalents and restricted cash, beginning of period" for fiscal 2024 excludes the fiscal 2023 "Cash and cash equivalents in Current assets of discontinued operations" of $36.1 million.